GLENMEDE TRUST CO NA - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 240 filers reported holding NEOGENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q3 2023$13,707,009
-29.8%
1,114,391
-1.1%
0.08%
-29.7%
Q2 2023$19,528,321
-0.3%
1,126,881
+0.2%
0.11%0.0%
Q1 2023$19,579,477
+91.0%
1,124,611
+1.4%
0.11%
+85.0%
Q4 2022$10,250,356
-5.3%
1,109,346
-11.8%
0.06%
-11.8%
Q3 2022$10,824,000
+12.1%
1,257,286
+6.1%
0.07%
+19.3%
Q2 2022$9,653,000
+16.0%
1,184,671
+73.0%
0.06%
+39.0%
Q1 2022$8,321,000
-48.9%
684,883
+43.4%
0.04%
-46.8%
Q4 2021$16,292,000
+0.1%
477,513
+41.5%
0.08%
-8.3%
Q3 2021$16,275,000
+4.4%
337,389
-2.2%
0.08%
+3.7%
Q2 2021$15,584,000
-6.8%
345,024
-0.5%
0.08%
-10.0%
Q1 2021$16,717,000
-28.2%
346,641
-19.9%
0.09%
-29.7%
Q4 2020$23,296,000
-1.6%
432,718
-32.6%
0.13%
-9.9%
Q3 2020$23,667,000
+4.8%
641,586
-12.0%
0.14%
+2.9%
Q2 2020$22,593,000
-27.3%
729,296
-31.3%
0.14%
-2.8%
Q1 2020$31,071,0000.0%1,062,2660.0%0.14%0.0%
Q4 2019$31,071,000
+35.0%
1,062,266
-11.8%
0.14%
+35.2%
Q3 2019$23,022,000
-19.4%
1,204,147
-7.5%
0.10%
-16.0%
Q2 2019$28,565,000
+612.3%
1,302,016
+564.1%
0.12%
+594.4%
Q1 2019$4,010,000
+36354.5%
196,046
+22052.1%
0.02%
Q4 2018$11,000
-90.4%
885
-88.2%
0.00%
Q3 2018$114,0007,5250.00%
Other shareholders
NEOGENOMICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Kopp Family Office, LLC 1,516,313$14,0118.43%
Greenhouse Funds LLLP 2,795,231$25,827,9342.36%
First Light Asset Management, LLC 2,682,171$24,783,2602.30%
PERKINS CAPITAL MANAGEMENT INC 197,700$1,8271.93%
Altium Capital Management LP 285,000$2,633,4001.34%
EMERALD MUTUAL FUND ADVISERS TRUST 1,654,543$15,287,9770.95%
EMERALD ADVISERS, LLC 2,101,567$19,418,4790.94%
Bullseye Asset Management LLC 105,997$9800.53%
OAK FAMILY ADVISORS, LLC 101,194$935,0330.50%
FORMULA GROWTH LTD 180,300$1,665,9720.47%
View complete list of NEOGENOMICS INC shareholders